Segra International has acquired Klonetics Plant Science Inc., a licensed cannabis nursery and cultivation company based in Kelowna, British Columbia. By integrating with Klonetics, Segra hopes to elevate the quality and diversity of cannabis genetics available to its clients.
Leveraging Klonetics' existing licenses and infrastructure, Segra plans to expand its nursery capacity and operational capabilities, enriched by Segra's tissue culture and molecular laboratories. Furthermore, the utilization of Klonetics' flowering capacity will support research and development, cultivar characterization, and performance validation of new genetics.
Jamie Blundell, CEO of Segra International, expressed: "The amalgamation with Klonetics marks an important milestone in our growth. By combining Klonetics' facility with Segra's advanced tissue culture, genetics, and global sales force, we are well-positioned to accelerate our growth and service to the global cannabis industry."
Segra is in the process of initiating facility upgrades to ensure immediate operational readiness. This expanded capacity will empower Segra to consistently deliver clean, pathogen-tested, and genetically authentic cannabis plants and premium flowers to clients across Canadian and international markets.
For more information:
Segra International Corp.
#108 – 21300 Gordon Way
Richmond, BC, Canada
segra-intl.com